Free Trial

Kymera Therapeutics (KYMR) SEC Filings & 10K Form

Kymera Therapeutics logo
$44.10 +1.51 (+3.55%)
Closing price 04:00 PM Eastern
Extended Trading
$43.54 -0.56 (-1.26%)
As of 07:51 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Kymera Therapeutics SEC Filings

DateFilerForm TypeView
08/12/2025
9:34 AM
Kymera Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SCHEDULE 13G/A
08/11/2025
6:10 AM
Kymera Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/11/2025
6:15 AM
Kymera Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/17/2025
7:12 PM
BlackRock, Inc. (Filed by)
Kymera Therapeutics (Subject)
Form SCHEDULE 13G/A
07/01/2025
5:41 PM
BIOTECHNOLOGY VALUE FUND II LP (Reporting)
BIOTECHNOLOGY VALUE FUND L P (Reporting)
Biotechnology Value Trading Fund OS LP (Reporting)
BVF GP HOLDINGS LLC (Reporting)
BVF I GP LLC (Reporting)
BVF II GP LLC (Reporting)
BVF INC/IL (Reporting)
BVF PARTNERS L P/IL (Reporting)
BVF Partners OS Ltd. (Reporting)
Kymera Therapeutics (Issuer)
LAMPERT MARK N (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/30/2025
7:26 PM
BAKER BROS. ADVISORS LP (Filed by)
Kymera Therapeutics (Subject)
Form SCHEDULE 13D/A
06/30/2025
7:15 PM
667, L.P. (Reporting)
Baker Bros. Advisors LLC (0001580575) (Reporting)
BAKER BROS. ADVISORS LP (Reporting)
Baker Brothers Life Sciences LP (Reporting)
BAKER FELIX (Reporting)
BAKER JULIAN (Reporting)
Kymera Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2025
3:32 PM
Kymera Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/26/2025
8:00 PM
Kymera Therapeutics (Issuer)
Ridloff Elena (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2025
8:00 PM
Kymera Therapeutics (Issuer)
Sandor Victor (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2025
8:00 PM
Booth Bruce (Reporting)
Kymera Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2025
8:00 PM
Kymera Therapeutics (Issuer)
MARAGANORE JOHN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2025
8:00 PM
Esposito Pamela (Reporting)
Kymera Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2025
8:00 PM
Hrustanovic Gorjan (Reporting)
Kymera Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2025
8:00 PM
Albers Jeffrey W. (Reporting)
Kymera Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2025
8:00 PM
667, L.P. (Reporting)
Baker Bros. Advisors LLC (0001580575) (Reporting)
BAKER BROS. ADVISORS LP (Reporting)
Baker Brothers Life Sciences LP (Reporting)
BAKER FELIX (Reporting)
BAKER JULIAN (Reporting)
Kymera Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2025
3:21 PM
Kymera Therapeutics (Filer)
Form 424B5
06/25/2025
6:10 AM
Kymera Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/25/2025
6:12 AM
Kymera Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/11/2025
3:47 PM
Kymera Therapeutics (Issuer)
Ridloff Elena (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2025
5:30 PM
Albers Jeffrey W. (Reporting)
Kymera Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2025
5:30 PM
Kymera Therapeutics (Issuer)
Mainolfi Nello (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2025
5:30 PM
Kymera Therapeutics (Issuer)
Ridloff Elena (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2025
5:30 PM
Esposito Pamela (Reporting)
Kymera Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2025
3:31 PM
Kymera Therapeutics (Subject)
Mainolfi Nello (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/02/2025
7:30 AM
Kymera Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/02/2025
6:05 AM
Kymera Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/12/2025
9:44 AM
Kymera Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SCHEDULE 13G/A
05/09/2025
6:15 AM
Kymera Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/09/2025
6:05 AM
Kymera Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/29/2025
3:10 PM
Kymera Therapeutics (Filer)
Form DEFA14A
04/09/2025
7:00 AM
Goodman Noah (Reporting)
Kymera Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
04/09/2025
7:05 AM
Goodman Noah (Reporting)
Kymera Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2025
7:00 AM
Jacobs Bruce N. (Reporting)
Kymera Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2025
5:30 PM
Kymera Therapeutics (Issuer)
Mainolfi Nello (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2025
5:30 PM
Gollob Jared (Reporting)
Kymera Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2025
5:30 PM
Jacobs Bruce N. (Reporting)
Kymera Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2025
5:30 PM
Chadwick Jeremy G (Reporting)
Kymera Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2025
5:30 PM
Chiniara Ellen (Reporting)
Kymera Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2025
5:00 PM
Jacobs Bruce N. (Reporting)
Kymera Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/03/2025
5:00 PM
Chiniara Ellen (Reporting)
Kymera Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
Trump’s betrayal exposed (Ad)

Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.tc pixel

Millions of Americans are about to be wiped out, while others could make a fortune… click here to ma
03/03/2025
5:00 PM
Chadwick Jeremy G (Reporting)
Kymera Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/03/2025
5:00 PM
Gollob Jared (Reporting)
Kymera Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/03/2025
3:30 PM
Kymera Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/27/2025
6:33 AM
Kymera Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/27/2025
6:13 AM
Kymera Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/27/2025
6:15 AM
Kymera Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/10/2025
9:25 AM
Kymera Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SCHEDULE 13G/A
01/14/2025
3:02 PM
Kymera Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/13/2025
6:00 AM
Jacobs Bruce N. (Reporting)
Kymera Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2025
6:00 AM
Kymera Therapeutics (Issuer)
Mainolfi Nello (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/02/2024
6:50 PM
Esposito Pamela (Reporting)
Kymera Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/02/2024
3:41 PM
Esposito Pamela (Reporting)
Kymera Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/14/2024
8:30 AM
Avoro Capital Advisors LLC (Filed by)
Kymera Therapeutics (Subject)
Form SC 13G/A
11/08/2024
9:52 AM
Kymera Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G/A
10/31/2024
7:13 AM
Kymera Therapeutics (Filer)
Form S-3ASR
10/31/2024
6:40 AM
Kymera Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/31/2024
6:45 AM
Kymera Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
09/17/2024
5:20 PM
Esposito Pamela (Reporting)
Kymera Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2024
3:40 PM
Esposito Pamela (Reporting)
Kymera Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/26/2024
5:31 PM
Albers Jeffrey W. (Reporting)
Kymera Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/26/2024
3:32 PM
Horobin Joanna (Reporting)
Kymera Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/26/2024
3:25 PM
Albers Jeffrey W. (Reporting)
Kymera Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/22/2024
4:06 PM
BIOTECHNOLOGY VALUE FUND II LP (Reporting)
BIOTECHNOLOGY VALUE FUND L P (Reporting)
Biotechnology Value Trading Fund OS LP (Reporting)
BVF GP HOLDINGS LLC (Reporting)
BVF I GP LLC (Reporting)
BVF II GP LLC (Reporting)
BVF INC/IL (Reporting)
BVF PARTNERS L P/IL (Reporting)
BVF Partners OS Ltd. (Reporting)
Kymera Therapeutics (Issuer)
LAMPERT MARK N (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2024
3:15 PM
BAKER BROS. ADVISORS LP (Filed by)
Kymera Therapeutics (Subject)
Form SC 13D/A
08/22/2024
3:03 PM
667, L.P. (Reporting)
Baker Bros. Advisors LLC (0001580575) (Reporting)
BAKER BROS. ADVISORS LP (Reporting)
Baker Brothers Life Sciences LP (Reporting)
BAKER FELIX (Reporting)
BAKER JULIAN (Reporting)
Kymera Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:KYMR) was last updated on 8/22/2025 by MarketBeat.com Staff
From Our Partners